Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$8.32 - $15.45 $14,144 - $26,265
1,700 New
1,700 $14,000
Q3 2020

Oct 09, 2020

SELL
$8.99 - $10.74 $664,522 - $793,879
-73,918 Closed
0 $0
Q2 2020

Jul 10, 2020

BUY
$9.14 - $11.97 $355,710 - $465,848
38,918 Added 111.19%
73,918 $762,000
Q1 2020

Apr 09, 2020

BUY
$8.58 - $14.01 $300,300 - $490,350
35,000 New
35,000 $353,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $679M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.